Lysophosphatidylcholine (LPC) is a bioactive proinflammatory lipid generated by
pathological activities. LPC is also a major phospholipid component of oxidized low-density …

Lysophosphatidylcholine (LPC) is a major plasma lipid that has been recognized as an
important cell signalling molecule produced under physiological conditions by the action of …

Lysophosphatidylcholines are a group of bioactive lipids heavily investigated in the context
of inflammation and atherosclerosis development. While present in plasma during …

Lysophosphatidylcholine (LPC) is the major bioactive lipid component of oxidized LDL,
thought to be responsible for many of the inflammatory effects of oxidized LDL described in …

Lysophosphatidylcholine (LPC) has been attributed a pro-inflammatory role in
atherosclerosis. Cell culture studies have identified stimulation of cytokine expression and …

Lysophosphatidylcholine (LPC) is the main component of oxidatively damaged low-density
lipoprotein (oxLDL). LPC originates from the cleavage of phosphatidylcholine by …

Oxidatively modified low-density lipoprotein (oxLDL) plays a key role in the initiation of
atherosclerosis by increasing monocyte adhesion. The mechanism that is responsible for …

Lysophosphatidic acid (LPA) is a collective name for a set of bioactive lipid species. Via six
widely distributed G protein-coupled receptors (GPCRs), LPA elicits a plethora of biological …

Lysophosphatidic acid (LPA) is a potent bioactive phospholipid. As many other biological
active lipids, LPA is an autacoid: it is formed locally on demand, and it acts locally near its …

Lysophosphatidylcholine (LPC) is the major component of oxidized low density lipoprotein
(oxLDL) and it has the ability to initiate or amplify several steps in atherogenesis due to its …